Evo Labs Research
A permanent record of what we could see on 2026-09-17. Share it, cite it, or download it.
EVO Labs Research displays third-party lab testing reports from Janoshik and Kovera Labs for listed batch lots.
EVO Labs Research operates out of Tampa, Florida, offering research peptides with linked batch testing reports from Janoshik Analytical and Kovera Labs. Standard payment options are available alongside explicit Research Use Only disclaimers.
Confidence: high · 7 pages read · 1 document opened · 2026-09-17 08:56 UTC
We could read most of what matters, lab evidence included.
Strong. Top quarter of the 125 research suppliers we have scored (median 6.0).
- Strong8.0 – 10
- Good6.5 – 7.9
- Mixed5.0 – 6.4
- Weak0 – 4.9
- 1Verify specific third-party lab certificates directly on Janoshik or Kovera databases for matching lot numbers.
- 2Confirm whether cold-chain temperature control is necessary for your specific peptide during transit.
Third-party test reports: are they recent, lot-linked, and do they use methods that can actually prove identity and amount?
- Published test reportsClear
1 of 1 document link we tried opened publicly.
- Reports tied to a lotFlagged
The reports we saw are not tied to a lot or batch, so they cannot tell you about the specific vial you would receive.
- What the reports sayClear
References independent testing by Janoshik Analytical and Kovera Labs.
- Analytical methodClear
COA pages state testing via HPLC and Mass Spectrometry (LC-MS).
- Named third-party labClear
The site names an outside lab we recognise: janoshik.
- Document recencyNot visible
The documents carry no date we could read from the server.
- COA
Opened publicly, contents not readable. No lot or batch reference.
The link returns text/html; charset=utf-8 rather than a document file. Nothing in the link or its label ties this report to a specific lot or batch.
Third-party ratings and public threads, read directly at the moment of this check. They are easy to buy and easy to brigade, so they are weighted low and can never overturn a lab-evidence flag. Every source below is also logged in the evidence trail.
Trustpilot did not answer, so we treat their reputation there as not visible.
Read 2026-09-17 08:56 UTC
Google shows 85.0/5.
Read 2026-09-17 08:56 UTC
No public community discussion we could read. Silence is not a verdict either way.
Read 2026-09-17 08:56 UTC
Every claim in this report traces to one of the items above. Expand a row to see the material it is based on.
The score is a weighted mean over the pillars we could actually read — 100% of the model on this run. Anything we could not see is left out of the maths rather than counted against the seller.
Model weight 34% · pillar score 8.0/10 · 4 ok, 1 flagged, 1 unseen
Model weight 24% · pillar score 10.0/10 · 6 ok, 0 flagged, 1 unseen
Model weight 18% · pillar score 10.0/10 · 1 ok, 0 flagged, 2 unseen
Model weight 12% · pillar score 6.7/10 · 2 ok, 1 flagged, 0 unseen
Model weight 12% · pillar score 10.0/10 · 1 ok, 0 flagged, 2 unseen
Reputation is deliberately the lightest pillar. Even a perfect rating cannot lift a report over a lab-evidence flag.
Paste the citation straight into a paper or a reference manager. Both files carry the run identifier and the timestamp of this report.
MyDosage. MyDosage supply check: Evo Labs Research (8.9/10). 2026-09-17. https://mydosage.com/c/58c83062-2d61-4517-b911-aac24c5ffa7b
The pack is one PDF: the verdict page plus an appendix of every cited page, document and social-proof source with the text we read. The data exports carry the same thing in machine form — inputs, every source with its timestamp and confidence weight, and the full scoring breakdown.
Whatever this report said, there are three ways to get what you need.
- 1Doctor + approved medicineA prescription and a pharmacy-dispensed product with a regulator's label.
- 2Clinic + licensed compounding pharmacyA prescriber and a pharmacy we checked against its licence register.
- 3Research-use-only supplierNo medical oversight. Only worth it when nothing approved exists yet.
Prices, oversight and typical wait are compared side by side for United States.